genprowebdirectory
Facebook Linkedin RSS Twitter Youtube
  • GEN Edge
    • Featured News
    • Multimedia
  • News
    • Insights
  • Topics
    • Artificial Intelligence
    • Bioprocessing
    • Cancer
    • Drug Discovery
    • Genome Editing
    • Infectious Diseases
    • OMICs
    • Translational Medicine
  • Magazine
    • Browse Issues
    • Subscribe
  • Multimedia
    • Summits
    • Webinars
    • GEN Live
    • Learning Labs
    • Podcasts
  • Resources
    • A-Lists
    • eBooks/Perspectives
    • Tutorials
    • Peer-Reviewed Journals
      • GEN Biotechnology
      • Re:Gen Open
    • New Products
    • Conference Calendar
  • Subscribe
    • Get GEN Magazine
    • Get GEN eNewsletters
Search
Facebook Linkedin RSS Twitter Youtube
Sign in
Welcome! Log into your account
Forgot your password? Get help
Privacy Policy
Password recovery
Recover your password
A password will be e-mailed to you.
Genetic Engineering & Biotechnology News GEN – Genetic Engineering and Biotechnology News
Genetic Engineering & Biotechnology News Genetic Engineering & Biotechnology News
  • GEN Edge
    • Featured News
    • Multimedia
  • News
    • Insights
  • Topics
    • Artificial Intelligence
    • Bioprocessing
    • Cancer
    • Drug Discovery
    • Genome Editing
    • Infectious Diseases
    • OMICs
    • Translational Medicine
  • Magazine
    • Browse Issues
    • Subscribe
  • Multimedia
    • Summits
    • Webinars
    • GEN Live
    • Learning Labs
    • Podcasts
  • Resources
    • A-Lists
    • eBooks/Perspectives
    • Tutorials
    • Peer-Reviewed Journals
      • GEN Biotechnology
      • Re:Gen Open
    • New Products
    • Conference Calendar
  • Subscribe
    • Get GEN Magazine
    • Get GEN eNewsletters
Home Authors Posts by Alex Philippidis

Alex Philippidis

Morphic Therapeutic researchers in the company's lab.
Drug Discovery

Lilly to Acquire Morphic for $3.2B, Adding Phase II IBD Programs

Single cell biology image from Getty Images
OMICs

Aiming High: 10x, NanoString Launch Large-Scale Panels

Eli Lilly researchers working in the company's laboratory
Drug Discovery

FDA Approves Lilly’s Amyloid-Targeting Kisunla for Early Alzheimer’s

Two researchers working in Absci's laboratory,
Artificial Intelligence

Absci Eyes Busy 2025 as Lead AI-Designed Candidate Heads for Clinic

One of Ginkgo Bioworks'
GEN Edge

StockWatch: Layoffs, ARK Selloff Sink Ginkgo Bioworks

A GeoVax researcher in the company's lab.
Infectious Diseases

GeoVax Advances COVID-19 Vaccine with Up to $45M from BARDA

Rendering of Novo Nordisk's planned $4.1 billion fill-finish plant in Clayton, NC.
Bioprocessing

Novo Nordisk Plans $4.1B Fill-Finish Plant at Clayton, NC, Campus

A Grail researcher working in the company’s lab.
OMICs

StockWatch: “Final Resolution” Set for Illumina’s Grail Saga

Image of Insilico Medicine's 6th generation Intelligent Robotics Drug Discovery Lab, from a recent video of the company's operations posted June 17 on YouTube
Artificial Intelligence

Insilico Moves HQ to Cambridge, MA, Completes IPF Trial Enrollment

Image of antibody-drug conjugates
Cancer

FDA Imposes Partial Hold on BioNTech/MedLink ADC Trial after Three Patient Deaths

1 2 3 … 292 > Page 1 of 292

Read the Digital Edition

June 2024 cover

Explore

  • About GEN
  • Contact GEN
  • GEN Staff
  • Editorial Guidelines
  • Reprints and Permissions
  • Scientific Advisory Board

Advertise

  • Media Kit and Planning Calendar
  • Advertising Terms and Conditions

Resources

  • Get the GEN Magazine
  • Get the GEN Email Newsletter
  • Inside Precision Medicine
  • Privacy Policy
Copyright © 2024 Genetic Engineering & Biotechnology News. All Rights Reserved.
Scroll Up